Mizuho Securities Assumes CASI Pharmaceuticals (CASI) at Buy
Tweet
Share
E-mailGet Alerts CASI Hot Sheet
Price: $0.21 --0%
Rating Summary:
5 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
5 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Mizuho Securities analyst Mara Goldstein assumes coverage on CASI Pharmaceuticals (NASDAQ: CASI) with a Buy rating and a price target of $3.80.
For an analyst ratings summary and ratings history on CASI Pharmaceuticals click here. For more ratings news on CASI Pharmaceuticals click here.
Shares of CASI Pharmaceuticals closed at $0.90 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ICICI Securities Resumes Oberoi Realty Ltd (OBER:IN) at Buy (1)
- Raymond James Starts Polaryx Therapeutics (PLYX) at Strong Buy
- JPMorgan Assumes salesforce.com (CRM) at Overweight, 'Overblown Concerns'
Create E-mail Alert Related Categories
New CoverageRelated Entities
Mara GoldsteinSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
